Detalhe da pesquisa
1.
Target product profiles: tests for tuberculosis treatment monitoring and optimization.
Bull World Health Organ
; 101(11): 730-737, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961060
2.
Low Body Mass Index at Treatment Initiation and Rifampicin-Resistant Tuberculosis Treatment Outcomes: An Individual Participant Data Meta-Analysis.
Clin Infect Dis
; 75(12): 2201-2210, 2022 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35476134
3.
Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness.
PLoS Med
; 19(6): e1004032, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35696431
4.
Prioritising attributes for tuberculosis preventive treatment regimens: a modelling analysis.
BMC Med
; 20(1): 182, 2022 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35581650
5.
Framework for the evaluation of new tests for tuberculosis infection.
Eur Respir J
; 58(2)2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33479110
6.
Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis.
Emerg Infect Dis
; 26(3)2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31922953
7.
Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data.
PLoS Med
; 17(1): e1003008, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31961877
8.
The safety of isoniazid tuberculosis preventive treatment in pregnant and postpartum women: systematic review and meta-analysis.
Eur Respir J
; 55(3)2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32217619
9.
Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis.
Eur Respir J
; 55(3)2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31862767
10.
Analysis of loss to follow-up in 4099 multidrug-resistant pulmonary tuberculosis patients.
Eur Respir J
; 54(1)2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31073080
11.
Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies.
PLoS Med
; 15(7): e1002595, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29969463
12.
Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
PLoS Med
; 15(7): e1002591, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29995958
13.
The impact of digital health technologies on tuberculosis treatment: a systematic review.
Eur Respir J
; 51(1)2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29326332
14.
Evaluating the potential costs and impact of digital health technologies for tuberculosis treatment support.
Eur Respir J
; 52(5)2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30166325
15.
Wider access to quality-assured rifapentine-based regimens is needed to accelerate tuberculosis prevention and care globally.
Eur Respir J
; 60(2)2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35777762
16.
Global reporting on tuberculosis preventive treatment among contacts.
Eur Respir J
; 59(3)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086827
17.
World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update.
Eur Respir J
; 49(3)2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28331043
18.
Commemorating World Tuberculosis Day 2022: recent ERJ articles of critical relevance to ending TB and saving lives.
Eur Respir J
; 59(3)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35332091
19.
Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses.
Eur Respir J
; 50(1)2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28751411
20.
Monitoring Therapy Compliance of Tuberculosis Patients by using Video-Enabled Electronic Devices.
Emerg Infect Dis
; 22(3): 538-40, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26891363